Skip to content

Clinical trials

Phase 1 Gastroesophageal Reflux trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Gastroesophageal Reflux Phase: Phase 1 Country / region: United States Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20062
20073
20082
20094
20103
20111
20131
20143
20151
20171
20223
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22
Terminated3
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Phathom Pharmaceuticals, Inc.3
Takeda3
University of North Carolina, Chapel Hill3
Janssen Research & Development, LLC2
Anandasabapathy, Sharmila, M.D.1
Children's Mercy Hospital Kansas City1
Eisai Co., Ltd.1
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.1
Main Line Health1
Mayo Clinic1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Gastroesophageal Reflux26
Heartburn5
Barrett Esophagus4
Esophagitis2
Laryngopharyngeal Reflux2
Obesity2
Asthma1
Duodenal Ulcer1
Gastrointestinal Neoplasms1
Idiopathic Pulmonary Fibrosis1

Trials

Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.